- Previous Close
0.0480 - Open
0.0303 - Bid --
- Ask --
- Day's Range
0.0302 - 0.0393 - 52 Week Range
0.0302 - 0.0393 - Volume
19,993 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 3.56
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
cardiodiagnosticsinc.comRecent News: CDIOW
View MoreCompare To: CDIOW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CDIOW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-69.36%
Return on Equity (ttm)
-133.96%
Revenue (ttm)
34.89k
Net Income Avi to Common (ttm)
-8.38M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
7.83M
Total Debt/Equity (mrq)
10.15%
Levered Free Cash Flow (ttm)
-2.41M